These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21493752)

  • 1. Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.
    Mueller M; Goodwin AK; Ator NA; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2011 Jul; 338(1):310-7. PubMed ID: 21493752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons.
    Goodwin AK; Mueller M; Shell CD; Ricaurte GA; Ator NA
    J Pharmacol Exp Ther; 2013 Jun; 345(3):342-53. PubMed ID: 23516331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses.
    Mueller M; Peters FT; Maurer HH; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2008 Oct; 327(1):38-44. PubMed ID: 18591215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
    Mueller M; Yuan J; Felim A; Neudörffer A; Peters FT; Maurer HH; McCann UD; Largeron M; Ricaurte GA
    Drug Metab Dispos; 2009 Oct; 37(10):2079-86. PubMed ID: 19628751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
    Mueller M; Maldonado-Adrian C; Yuan J; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2013 Feb; 344(2):479-88. PubMed ID: 23209329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans.
    Mueller M; Kolbrich EA; Peters FT; Maurer HH; McCann UD; Huestis MA; Ricaurte GA
    Ther Drug Monit; 2009 Jun; 31(3):367-73. PubMed ID: 19417716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.
    Segura M; Farré M; Pichini S; Peiró AM; Roset PN; Ramírez A; Ortuño J; Pacifici R; Zuccaro P; Segura J; de la Torre R
    Clin Pharmacokinet; 2005; 44(6):649-60. PubMed ID: 15910012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans.
    Segura M; Ortuño J; Farré M; McLure JA; Pujadas M; Pizarro N; Llebaria A; Joglar J; Roset PN; Segura J; de La Torre R
    Chem Res Toxicol; 2001 Sep; 14(9):1203-8. PubMed ID: 11559034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice.
    Escobedo I; O'Shea E; Orio L; Sanchez V; Segura M; de la Torre R; Farre M; Green AR; Colado MI
    Br J Pharmacol; 2005 Jan; 144(2):231-41. PubMed ID: 15665862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat.
    Baumann MH; Zolkowska D; Kim I; Scheidweiler KB; Rothman RB; Huestis MA
    Drug Metab Dispos; 2009 Nov; 37(11):2163-70. PubMed ID: 19679675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.
    Mueller M; Yuan J; McCann UD; Hatzidimitriou G; Ricaurte GA
    Int J Neuropsychopharmacol; 2013 May; 16(4):791-801. PubMed ID: 22824226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
    Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R
    J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
    Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
    Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
    Concheiro M; Baumann MH; Scheidweiler KB; Rothman RB; Marrone GF; Huestis MA
    Drug Metab Dispos; 2014 Jan; 42(1):119-25. PubMed ID: 24141857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons.
    Mechan A; Yuan J; Hatzidimitriou G; Irvine RJ; McCann UD; Ricaurte GA
    Neuropsychopharmacology; 2006 Feb; 31(2):339-50. PubMed ID: 15999148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans.
    Yubero-Lahoz S; Pardo R; Farré M; O'Mahony B; Torrens M; Mustata C; Pérez-Mañá C; Carbó ML; de la Torre R
    Clin Pharmacokinet; 2011 May; 50(5):319-29. PubMed ID: 21456632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma.
    Mueller M; Peters FT; Ricaurte GA; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):262-70. PubMed ID: 17646137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic neurotoxic thioether metabolites of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): synthesis, isolation, and characterization of diastereoisomers.
    Pizarro N; de la Torre R; Joglar J; Okumura N; Perfetti X; Lau SS; Monks TJ
    Chem Res Toxicol; 2008 Dec; 21(12):2272-9. PubMed ID: 19548351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice.
    Scheidweiler KB; Ladenheim B; Barnes AJ; Cadet JL; Huestis MA
    J Anal Toxicol; 2011 Sep; 35(7):470-80. PubMed ID: 21871156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans.
    Fallon JK; Kicman AT; Henry JA; Milligan PJ; Cowan DA; Hutt AJ
    Clin Chem; 1999 Jul; 45(7):1058-69. PubMed ID: 10388483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.